APA (7th ed.) Citation

ER, B., M, B., HD, H., PG, R., T, N., JP, K., . . . L, V. L. (2016). A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study. Gynecologic oncology, 140(1), 48. https://doi.org/10.1016/j.ygyno.2015.11.027

Chicago Style (17th ed.) Citation

ER, Burton, Brady M, Homesley HD, Rose PG, Nakamura T, Kesterson JP, Rotmensch J, Tate Thigpen J, and Van Le L. "A Phase II Study of Paclitaxel for the Treatment of Ovarian Stromal Tumors: An NRG Oncology/ Gynecologic Oncology Group Study." Gynecologic Oncology 140, no. 1 (2016): 48. https://doi.org/10.1016/j.ygyno.2015.11.027.

MLA (9th ed.) Citation

ER, Burton, et al. "A Phase II Study of Paclitaxel for the Treatment of Ovarian Stromal Tumors: An NRG Oncology/ Gynecologic Oncology Group Study." Gynecologic Oncology, vol. 140, no. 1, 2016, p. 48, https://doi.org/10.1016/j.ygyno.2015.11.027.